Roberts Glore & Co. Inc. IL Invests $591,000 in HCA Healthcare, Inc. $HCA

Roberts Glore & Co. Inc. IL acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 1,517 shares of the company’s stock, valued at approximately $591,000.

Other large investors have also recently made changes to their positions in the company. BlackRock Inc. purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at about $5,069,974,000. Norges Bank purchased a new stake in HCA Healthcare in the 4th quarter worth $1,262,513,000. Legal & General Group Plc purchased a new stake in shares of HCA Healthcare during the second quarter worth approximately $410,992,000. Jupiter Topco LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $371,138,000. Finally, Life Cycle Investment Partners Ltd acquired a new position in HCA Healthcare in the 4th quarter valued at about $374,037,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Down 0.1%

Shares of HCA stock opened at $428.90 on Wednesday. The company has a market capitalization of $92.86 billion, a PE ratio of 14.36, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The firm has a fifty day simple moving average of $398.59 and a 200-day simple moving average of $442.83.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the previous year, the firm posted $6.84 earnings per share. The business’s revenue was up 8.7% on a year-over-year basis. Equities research analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Barclays reduced their price objective on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a report on Monday, July 27th. Truist Financial reduced their price target on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Robert W. Baird lowered their target price on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a report on Monday, July 27th. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Finally, Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a report on Tuesday, July 14th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $462.64.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.